Ruberto S, Dominguez-Mozo M, Garcia-Martinez M, Cossu D, Sechi L, Alvarez-Lafuente R
Front Immunol. 2025; 15():1505239.
PMID: 39850873
PMC: 11754046.
DOI: 10.3389/fimmu.2024.1505239.
Singh R, Vangala R, Torne A, Bose D, Robertson E
Front Microbiol. 2025; 15:1484455.
PMID: 39839102
PMC: 11747046.
DOI: 10.3389/fmicb.2024.1484455.
SoRelle E, Haynes L, Willard K, Chang B, Chng J, Christofk H
PLoS Pathog. 2024; 20(10):e1012341.
PMID: 39446925
PMC: 11563402.
DOI: 10.1371/journal.ppat.1012341.
SoRelle E, Haynes L, Willard K, Chang B, Chng J, Christofk H
bioRxiv. 2024; .
PMID: 38915538
PMC: 11195279.
DOI: 10.1101/2024.06.14.598975.
Ungerleider N, Roberts C, OGrady T, Nguyen T, Baddoo M, Wang J
Nucleic Acids Res. 2024; 52(9):5016-5032.
PMID: 38471819
PMC: 11109974.
DOI: 10.1093/nar/gkae175.
A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.
Ward B, Prasai K, Schaal D, Wang J, Scott R
PLoS Pathog. 2023; 19(12):e1011873.
PMID: 38113273
PMC: 10763950.
DOI: 10.1371/journal.ppat.1011873.
Epstein-Barr virus and host cell 3D genome organization.
Wang C, Zhao B
J Med Virol. 2023; 95(11):e29234.
PMID: 37988227
PMC: 10664867.
DOI: 10.1002/jmv.29234.
Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer.
MacLennan S, Marra M
Int J Mol Sci. 2023; 24(11).
PMID: 37298494
PMC: 10253656.
DOI: 10.3390/ijms24119543.
Epstein-Barr virus: the molecular virology and the associated diseases.
Murata T
Fujita Med J. 2023; 9(2):65-72.
PMID: 37234394
PMC: 10206890.
DOI: 10.20407/fmj.2022-018.
EBV-associated diseases: Current therapeutics and emerging technologies.
Chakravorty S, Afzali B, Kazemian M
Front Immunol. 2022; 13:1059133.
PMID: 36389670
PMC: 9647127.
DOI: 10.3389/fimmu.2022.1059133.
Proteins That Read DNA Methylation.
Liu K, Shimbo T, Song X, Wade P, Min J
Adv Exp Med Biol. 2022; 1389:269-293.
PMID: 36350514
DOI: 10.1007/978-3-031-11454-0_11.
Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.
Ali A, Ohashi M, Casco A, Djavadian R, Eichelberg M, Kenney S
PLoS Pathog. 2022; 18(9):e1010886.
PMID: 36174106
PMC: 9553042.
DOI: 10.1371/journal.ppat.1010886.
Epstein-Barr virus: Biology and clinical disease.
Damania B, Kenney S, Raab-Traub N
Cell. 2022; 185(20):3652-3670.
PMID: 36113467
PMC: 9529843.
DOI: 10.1016/j.cell.2022.08.026.
High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD.
Lupo J, Wielandts A, Buisson M, Consortium C, Habib M, Hamoudi M
Pathogens. 2022; 11(8).
PMID: 36015048
PMC: 9413454.
DOI: 10.3390/pathogens11080928.
Whole-genome sequencing of Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) reveals evidence for two African lineages.
Moorad R, Juarez A, Landis J, Pluta L, Perkins M, Cheves A
Virology. 2022; 568:101-114.
PMID: 35152042
PMC: 8915436.
DOI: 10.1016/j.virol.2022.01.005.
Interaction sites of the Epstein-Barr virus Zta transcription factor with the host genome in epithelial cells.
Godfrey A, Osborn K, Sinclair A
Access Microbiol. 2022; 3(11):000282.
PMID: 35018326
PMC: 8742585.
DOI: 10.1099/acmi.0.000282.
Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.
Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y
Viruses. 2021; 13(12).
PMID: 34960613
PMC: 8706188.
DOI: 10.3390/v13122344.
Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1.
Bernaudat F, Gustems M, Gunther J, Oliva M, Buschle A, Gobel C
Nucleic Acids Res. 2021; 50(1):490-511.
PMID: 34893887
PMC: 8754650.
DOI: 10.1093/nar/gkab1183.
Epigenetic control of the Epstein-Barr lifecycle.
Guo R, Gewurz B
Curr Opin Virol. 2021; 52:78-88.
PMID: 34891084
PMC: 9112224.
DOI: 10.1016/j.coviro.2021.11.013.
Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
Fachko D, Chen Y, Skalsky R
J Virol. 2021; 96(4):e0149521.
PMID: 34878852
PMC: 8865410.
DOI: 10.1128/JVI.01495-21.
